The estimated Net Worth of Julie Andrews is at least $1.95 million dollars as of 17 August 2020. Ms. Andrews owns over 1,083 units of Wright Medical NV stock worth over $1,500,139 and over the last 9 years she sold WMGI stock worth over $449,812. In addition, she makes $0 as Senior Vice President et Global Finance at Wright Medical NV.
Julie has made over 15 trades of the Wright Medical NV stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 1,083 units of WMGI stock worth $32,685 on 17 August 2020.
The largest trade she's ever made was exercising 9,000 units of Wright Medical NV stock on 20 December 2019 worth over $174,240. On average, Julie trades about 987 units every 66 days since 2015. As of 17 August 2020 she still owns at least 50,038 units of Wright Medical NV stock.
You can see the complete history of Ms. Andrews stock trades at the bottom of the page.
Julie B. Andrews serves as Senior Vice President, Global Finance of the Company. From October 2015 to August 2019, Ms. Andrews served as Vice President of Finance, Chief Accounting Officer. Ms. Andrews served as Vice President and Chief Accounting Officer of Wright Medical Group, Inc. from May 2012 to October 2015. From February 1998 to May 2012, Ms. Andrews held numerous key financial positions with Medtronic, Inc., a global medical device company. Most recently, Ms. Andrews served as Medtronic’s Vice President, Finance for its spinal and biologics business units. Ms. Andrews has significant accounting, finance, and business skills as well as global experience, having held positions in worldwide planning and analysis in Medtronic Sofamor Danek and in Medtronic’s spinal and biologics business. Prior to joining Medtronic, Ms. Andrews worked with Thomas & Betts Corporation in Memphis, Tennessee and Thomas Havey, LLP in Chicago, Illinois.
Julie Andrews is 49, she's been the Senior Vice President et Global Finance of Wright Medical NV since 2019. There are 18 older and 5 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Julie's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman et Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: